Profile picture of Dr. Peter D. Sly

Pulmonologist

Australian Flag

Peter D. Sly

Icon representing available degree

MBBS & BMedSc; MD; DSc (Advanced)

Icon representing available city of this doctor

South Brisbane

Connect with Peter D. Sly

Social Profiles:

Quick Appointment for Peter D. Sly

No OPD information available

Services Offered by Peter D. Sly

  • Asthma

  • Cystic Fibrosis

  • Stridor

  • Asthma in Children

  • Bronchiectasis

  • Bronchitis

  • Spinal Muscular Atrophy (SMA)

  • Ataxia-Telangiectasia

  • Campylobacter Infection

  • Malnutrition

  • Muscle Atrophy

  • Parainfluenza

  • Pneumonia

  • Primary Lateral Sclerosis

  • Pseudomonas Stutzeri Infections

  • Spinal Muscular Atrophy Type 2

  • Spinal Muscular Atrophy Type 3

  • Allergic Rhinitis

  • Aspergillosis

  • Atopic Dermatitis

  • Autism Spectrum Disorder

  • Avian Influenza

  • Central Sleep Apnea

  • Chronic Obstructive Pulmonary Disease (COPD)

  • Flu

  • Food Allergy

  • Grass Allergy

  • Heavy Metal Poisoning

  • Hepatitis A

  • Obesity

  • Pulmonary Edema

  • Respiratory Syncytial Virus (RSV) Infection

  • Severe Acute Respiratory Syndrome (SARS)

  • Spinal Muscular Atrophy Type 1

  • Strep Throat

  • Telangiectasia

  • Tetanus

  • Typhoid Fever

  • Vitamin D Deficiency

About Of Peter D. Sly

Peter D. Sly is a male medical professional who helps patients with various health issues such as asthma, cystic fibrosis, and bronchitis. He also specializes in conditions like spinal muscular atrophy, autism spectrum disorder, and vitamin D deficiency.

Peter D. Sly uses special skills and treatments to care for his patients. He communicates with them in a way that makes them feel comfortable and confident in his care. Patients trust him because he listens to their concerns and explains things clearly.

Peter D. Sly stays updated with the latest medical knowledge and research to provide the best possible care to his patients. He works closely with other medical professionals to collaborate on treatment plans and share information.

His relationships with colleagues are strong, and he values teamwork in providing the best care for patients. Peter D. Sly's work has had a positive impact on many patients' lives by helping them manage their health conditions effectively.

One of Peter D. Sly's notable publications is a study on emergency department presentations related to asthma and allergic diseases in Australia. He has also conducted clinical trials to test new treatments for conditions like ataxia-telangiectasia.

Overall, Peter D. Sly is a dedicated medical professional who is committed to improving the health and well-being of his patients. His expertise, communication skills, and commitment to staying updated with the latest research make him a trusted and respected healthcare provider in his field.

Education of Peter D. Sly

  • MBBS & BMedSc, University of Melbourne

  • MD, University of Melbourne

  • DSc (Advanced), University of Western Australia

Publications by Peter D. Sly

Emergency department presentations related to asthma and allergic diseases in Central Queensland, Australia: a comparative analysis between First Nations Australians and Australians of other descents.

Journal: BMJ open
Year: March 04, 2025
Authors: Desalegn Shifti, Mahmudul Al Imam, Diane Maresco Pennisi, Renarta Whitcombe, Peter Sly, Craig Munns, Rachel Peters, Gulam Khandaker, Jennifer Koplin

Description:Objective: To examine the overall incidence rate and trends in emergency department (ED) presentations related to asthma and allergic diseases in regional Australia with a particular focus on First Nations Australians. Methods: A retrospective analysis of data from the Emergency Department Information System. Methods: This study used data from 12 public hospitals in Central Queensland, Australia, a region encompassing regional, rural and remote outback areas. Methods: A total of 813 112 ED presentations between 2018 and 2023. Methods: Asthma and allergic diseases were identified using the International Classification of Diseases-Tenth Revision-Australian Modification codes. Results: There were 13 273 asthma and allergic disease-related ED presentations, with an overall prevalence of 1.6% (95% CI 1.6, 1.7). There was a significantly higher incidence rate of asthma and allergic disease-related ED presentations among First Nations Australians at 177.5 per 10 000 person-years (95% CI 169.3, 186.0) compared with 98.9 per 10 000 person-years (95% CI 97.2, 100.8) among Australians of other descents. The incidence rates, with corresponding 95% CIs, of the four most common cases among First Nations Australians and Australians of other descents, respectively, were as follows: asthma (87.8 (82.0, 93.8) and 40.2 (39.0, 41.3)), unspecified allergy (55.3 (50.8, 60.2) and 36.0 (34.9, 37.1)), atopic/allergic contact dermatitis (17.1 (14.6, 19.9) and 10.6 (10.0, 11.2)) and anaphylaxis (7.2 (5.6, 9.1) and 6.2 (5.7, 6.6)). Conclusions: Our findings highlight a significantly higher rate of asthma and allergic disease-related ED presentations among First Nations Australians compared with Australians of other descents. This underscores the urgent need for targeted healthcare interventions integrating culturally appropriate approaches, alongside additional research to understand causality.

Early-life allergic sensitization and respiratory infection-Two hits on lung function?

Journal: Journal: Pediatric Allergy And Immunology : Official Publication Of The European Society Of Pediatric Allergy And Immunology
Year: March 19, 2025
Authors: Vikas Wadhwa, Shyamali Dharmage, Danielle Wurzel, Peter Sly, Cecilie Svanes, Adrian Lowe, N Idrose, Nilakshi Waidyatillake, Caroline Lodge, Melissa Russell

Description:Background: Allergic sensitization and respiratory infections commonly occur in childhood. Interplay between them in asthma development is known as the 'two-hit' hypothesis. There has been no previous investigation of this hypothesis on adult lung function. Objective: In a birth cohort at high risk for allergic diseases, we investigated interactions between these two factors and lung function outcomes into adulthood. Methods: Allergic sensitization was assessed at age 24 months by skin prick testing to aero and food allergens. Respiratory infection was defined as cough, rattle or wheeze measured by frequent questionnaires up to age 24 months. Regression models were utilized to identify interactions between these exposures and associations with lung function at ages 12, 18 and 25 years. Results: At age 25 years, those sensitized at age 2 years(n = 118) demonstrated reductions in pre-bronchodilator FEV1 of 0.06(95% CI: -0.12, 0.00, z-score units, p = .055) for each additional month of respiratory infections. Those not sensitized (n = 120) had increases in pre-bronchodilator FEV1 of 0.07 (95% CI: 0.02, 0.13, z-score units, p = .012) for each additional month of respiratory infection(pinteraction = .012). Similar findings were noted for FEV1/FVC ratio(pinteraction = .011), FEF25-75(pinteraction = .007) and absolute change in pre and post bronchodilator lung function. At 18 years, findings were similar; however, there was less evidence for interactions at 12 years. Conclusions: Our study findings support the 'two-hit' hypothesis of interactions between early-life allergic sensitization and increasing respiratory infections, and impairment in lung function up to age 25 years. Early childhood respiratory infections however had different impacts on lung function depending upon the presence or absence of allergic sensitization.

Associations between household characteristics and environmentally persistent free radicals in house dust from two Australian locations.

Journal: Frontiers In Public Health
Year: March 31, 2025
Authors: Wen Lee, Prakash Dangal, Gaurav Langan, Nina Lazarevic, Zhiwei Xu, Stephania Cormier, Slawo Lomnicki, Peter Sly, Dwan Vilcins

Description:The association between air pollution and adverse health outcomes has been extensively documented, with oxidative stress widely considered a contributing factor. However, the precise underlying mechanism(s) remains unclear. Recent studies suggest that environmentally persistent free radicals (EPFRs) may provide the missing connection between air pollution and its detrimental health effects. Nevertheless, the indoor environment has received limited attention in EPFR research. Therefore, in this study, we measured EPFRs in house dust samples from two locations in Australia and examined household characteristics associated with their presence. Household characteristics and behaviours that influence indoor air quality were collected from an online questionnaire; 24-h indoor and outdoor air quality were measured with a TSI DustTrak™ DRX Aerosol monitor 8,533; annual indoor and outdoor air quality were matched to two validated, satellite-based land-use regression models; and dust samples were collected from house vacuums. Dust samples were analyzed using nano electron paramagnetic resonance (EPR) to determine spin concentrations, g-factor, and delta H peak-to-peak (Hp-p). Key variables were identified using Lasso-penalized regression models, followed by unpenalized linear regression and post-selection inference to estimate coefficients and assess the robustness of the findings. Our analysis revealed that factors such as extractor fan usage during cooking, exposure to traffic-related air pollution and ambient PM2.5 levels, indoor combustion activities, seasonal variation, housing construction type, ventilation, and cleaning practices were significantly associated with EPFR concentrations in Australian homes. Notably, consistent use of extractor fans during cooking was strongly and consistently associated with lower EPFR concentrations in house dust across both study locations. Our research provided insight into the potential impact of household characteristics on EPFR concentrations, which can potentially lead to adverse health effects. Future research should link our research findings on factors affecting indoor EPFRs to their potential health effects.

Phthalates and bisphenols early-life exposure, and childhood allergic conditions: a pooled analysis of cohort studies.

Journal: Journal Of Exposure Science & Environmental Epidemiology
Year: May 07, 2025
Authors: Thomas Boissiere O'neill, Nina Lazarevic, Peter Sly, Anne-louise Ponsonby, Aimin Chen, Meghan Azad, Joseph Braun, Jeffrey Brook, David Burgner, Bruce Lanphear, Theo Moraes, Richard Saffery, Padmaja Subbarao, Stuart Turvey, Kimberly Yolton

Description:Background: Exposure to plastic additives, such as phthalates and bisphenols, has been associated with a higher risk of allergic conditions, but the evidence is inconsistent for children younger than five. Objective: To examine the association between pre- and postnatal urinary phthalates and bisphenols, and allergic conditions, and potential effect modification by sex, in pre-school children, through a pooled analysis. Methods: We pooled data from the Barwon Infant Study (Australia), the Canadian Healthy Infant Longitudinal Development Study (Canada), the Health Outcomes and Measures of the Environment (United States) and the Environmental Influences on Child Health Outcomes-wide cohorts (United States). Urinary phthalates and bisphenols were measured during pregnancy and early childhood. We estimated daily intakes from urinary concentrations, except for mono-(3-carboxypropyl) phthalate (MCPP). Outcomes, including asthma, wheeze, eczema, and rhinitis, were assessed up to five years of age through questionnaires and clinical assessments. We used generalised estimating equations for single compounds and quantile G-computation for the chemical mixtures. Results: 5306 children were included. A two-fold increase in prenatal dibutyl phthalates (DBP; risk ratio [RR] = 1.08; 95% confidence interval [CI]: 1.00-1.16) and benzyl butyl phthalate (BBzP; RR = 1.06; 95%CI: 1.00-1.12) increased the risk of asthma in children under five. Prenatal MCPP levels were associated with rhinitis (RR = 1.05; 95%CI: 1.01-1.09). Postnatal BBzP levels increased the risk of wheezing (RR = 1.05; 95%CI 1.01-1.09), as well as di(2-ethylhexyl) phthalate (DEHP; RR = 1.06; 95%CI: 1.01-1.11) and MCPP (RR = 1.09; 95%CI: 1.04-1.14). These were also inversely associated with eczema. A one-quartile increase in the postnatal chemical mixture increased the risk of wheezing (RR = 1.14; 95%CI: 1.02-1.26). There was limited evidence of effect modification by sex. Conclusions: Phthalates and bisphenols are widespread and may contribute to allergic conditions in children. We pooled data from 5000 children across multiple birth cohorts, suggesting that early-life exposure to these chemicals is associated with increased risks of asthma, wheezing, and rhinitis by age five. We further investigated the timing of exposure, non-linear dose-response relationships, and effect measure modification by sex. This study provides a comprehensive assessment of early-life exposure to phthalates and bisphenols and strengthens the evidence for their role in the development of childhood allergic outcomes.

Phthalates, bisphenols and per-and polyfluoroalkyl substances migration from food packaging into food: a systematic review.

Journal: Reviews On Environmental Health
Year: February 16, 2025
Authors: Madeline Tanzer, Thomas Boissiere O'neill, Peter Sly, Dwan Vilcins

Description:Endocrine-disrupting chemicals are commonly found in food due to their migration from plastic packaging. Despite their functional benefits, these additives can disrupt the endocrine system, leading to several adverse health outcomes. This review aims to examine the migration of phthalates, bisphenols, and per-and-polyfluoroalkyl substances (PFAS) from plastic food packaging into food substances. Six electronic databases were systematically screened for observational, case reports, or experimental studies investigating any food for human consumption exposed to food packaging. Sixty-seven studies, including 5,378 samples, were included. Phthalates and bisphenols consistently migrated from food packaging. PFAS migration was also detected but too few studies were published to draw conclusions. Migration rates were influenced by factors such as temperature, exposure time, and food composition, with high-fat or acidic foods leading to higher migration rates. Based on a standard Western Diet, 713.8 µg of di-2-ethylhexyl phthalate, 347.7 µg of di-n-butyl phthalate, 17.3 µg of butyl-benzyl phthalate, 35,250 µg of di-iso-decyl phthalate, and 65.4 µg of other plasticizers, totaling 36,349.2 µg, could be consumed from food packaging daily. However, these estimates may not be generalizable to other dietary patterns, such as Mediterranean or plant-based diets. Further research into low migration or safer alternative to current plasticizers, alongside regulatory efforts considering potential exposure via food contact materials may help reduce risks associated with endocrine-disrupting chemicals in food packaging.

Clinical Trials by Peter D. Sly

A Phase 2A/2B Placebo-controlled Randomised Clinical Trial to Test the Ability of Triheptanoin to Protect Primary Airway Epithelial Cells Obtained From Participants With Ataxia-telangiectasia Against Death Induced by Glucose Deprivation

Enrollment Status: Completed

Published: July 20, 2023

Intervention Type: Dietary supplement

Study Drug:

Study Phase: Phase 2

Frequently Asked Questions About Peter D. Sly

What conditions does Peter D. Sly specialize in treating as a pulmonologist?

Peter D. Sly specializes in treating a wide range of respiratory conditions such as asthma, COPD, bronchitis, and pneumonia, among others.

What diagnostic tests does Peter D. Sly offer to evaluate lung health?

Peter D. Sly offers diagnostic tests such as pulmonary function tests, bronchoscopy, chest X-rays, and CT scans to assess lung function and identify respiratory issues.

What treatment options does Peter D. Sly provide for patients with lung diseases?

Peter D. Sly offers personalized treatment plans that may include medications, inhalers, oxygen therapy, pulmonary rehabilitation, and lifestyle modifications to manage lung diseases effectively.

How can patients schedule an appointment with Peter D. Sly?

Patients can schedule an appointment with Peter D. Sly by contacting his clinic directly via phone or through the online appointment booking system available on his website.

What are some common symptoms that indicate a visit to Peter D. Sly, pulmonologist, is necessary?

Persistent cough, shortness of breath, wheezing, chest pain, and recurrent respiratory infections are common symptoms that may indicate the need to consult with Peter D. Sly for evaluation and treatment.

Does Peter D. Sly offer telemedicine consultations for patients unable to visit the clinic in person?

Yes, Peter D. Sly provides telemedicine consultations for patients who are unable to visit the clinic in person, offering convenient access to care and medical advice remotely.

More Pulmonologist Like Peter D. Sly in South Brisbane

Toparrow